epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Asthma/ Pulmonary

Subclasses

  • Adrenergic Agonists (Nonselective), Pulmonary
  • Alpha1-Proteinase Inhibitors
  • Antimicrobials, Inhaled
  • Beta-2 Agonists, Inhaled Long-Acting (LABAs)
  • Beta-2 Agonists, Inhaled Short-Acting (SABAs)
  • Beta-2 Agonists, Oral
  • Corticosteroids, Inhaled
  • Cystic Fibrosis
  • Diagnostic Agents, Pulmonary
  • Dipeptidyl Peptidase-1 (DPP-1) Inhibitors
  • Expectorants/ Mucolytics
  • IgE Antagonists
  • Interleukin-4/ 13 (IL-4/ 13) Antagonists
  • Interleukin-5 (IL-5) Antagonists
  • Interstitial Lung Disease
  • Leukotriene Inhibitors
  • Mast Cell Stabilizers, Inhaled
  • Methylxanthines, Pulmonary
  • Muscarinic Antagonists, Inhaled Long-Acting (LAMAs)
  • Muscarinic Antagonists, Inhaled Short-Acting (SAMAs)
  • Phosphodiesterase 3/ 4 (PDE3/ 4) Inhibitors, Pulmonary
  • Phosphodiesterase 4 (PDE4) Inhibitors, Pulmonary
  • Respiratory Stimulants, Central
  • Respiratory Syncytial Virus (RSV)
  • Sclerosing Agents, Pulmonary
  • Sleep-related Breathing Disorders
  • Surfactants
  • Thymic Stromal Lymphopoietin (TSLP) Antagonists

Expectorants/ Mucolytics

Drug Names

Generic Names

acetylcysteine generic  
guaifenesin generic  
Mucinex guaifenesin  
Mucinex Maximum Strength guaifenesin  
Mucomyst acetylcysteine  
Pulmozyme dornase alfa inhaled  
SSKI potassium iodide  

close

 

Select a medication above to begin.

Lokelma

sodium zirconium cyclosilicate

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  POWDER: 5 g per packet, 10 g per packet

hyperkalemia

[initial tx]
Dose: 10 g PO tid for up to 48h
[maintenance tx]
Dose: 10 g PO qd; Info: may incr. dose by 5 g/day no more frequently than qwk to target serum potassium levels; may decr. dose or D/C tx if serum potassium levels below target; dose range 5 g PO qod to 15 g PO qd

renal dosing

[see below]
renal impairment: not defined
HD: start 5 g qd on non-dialysis days, then may adjust dose based on predialysis potassium level after long interdialytic interval and target serum potassium levels with dose range 5-15 g qd on non-dialysis days; no dose on dialysis days; no supplement after dialysis; PD: not defined; Info: consider starting 10 g qd on non-hemodialysis days if K >6.5 mEq/L

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information